If you own shares in ENDRA Life Sciences Inc. (NASDAQ:NDRA) then it's worth thinking about how it contributes to the...
Supports Commercialization of TAEUS Liver Product Targeting NAFLD-NASH ANN ARBOR, MI / ACCESSWIRE / January 15, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic ...
ANN ARBOR, MI / ACCESSWIRE / May 6, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), has recently been issued design patents D883487 ...
ANN ARBOR, MI / ACCESSWIRE / March 26, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today provided a business update and ...
ANN ARBOR, MI / ACCESSWIRE / March 3, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced the appointment of Raza ...
ANN ARBOR, MI / ACCESSWIRE / May 14, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today provided a business update and ...
First regulatory clearance paves the way to commercialize TAEUS in European markets U.S. FDA submission expected during H1:20 ANN ARBOR, MI / ACCESSWIRE / March 10, 2020 / ENDRA Life Sciences Inc. ("ENDRA") ...
NIGER Delta Rights Advocates, NDRA, has warned the National Assembly to "totally reject" the virement request by the Interim Management Committee, IMC of Niger Delta Development Commission, NDDC, to justify bloated expenditure of the last three months. The p…
Conference call scheduled for 4:30 p.m. ET today ANN ARBOR, MI / ACCESSWIRE / November 13, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound ...
ANN ARBOR, MI / ACCESSWIRE / November 5, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its third quarter ...
Company guides to Q2:20 submission of 510(k) with robust filing package ANN ARBOR, MI / ACCESSWIRE / March 19, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer of Thermo Acoustic ...
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
ANN ARBOR, MI / ACCESSWIRE / March 9, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its fourth quarter ...
Executing Tactical Elements of EU Commercial Plan to Support Initial Launch Activities ANN ARBOR, MI / ACCESSWIRE / March 17, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer ...
Regulatory filing is a major step toward commercialization of TAEUS liver device ANN ARBOR, MI / ACCESSWIRE / December 19, 2019 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), the pioneer ...
ENDRA intends to use the net proceeds for working capital and general corporate purposes, including to support its commercialization initiatives and ongoing clinical studies. The company used approximately $1.9 million of net proceeds from the offering to repay debt represented by convertible promissory notes issued in July 2019.
Key Opinion Leader in hepatology and gastroenterology to discuss challenges and opportunities in NAFLD and NASH Company representatives to showcase TAEUS™ liver device in Exhibit Hall ANN ARBOR, MI / ACCESSWIRE ...
ANN ARBOR, MI / ACCESSWIRE / May 1, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its first quarter ...
ENDRA also provided an update on the status of its FDA 510(k) submission and intellectual property. "The receipt of the CE Mark for our TAEUS liver system in the first quarter was a key milestone, enabling ENDRA to initiate its plan to commercialize the company's disruptive technology in 2020," continued Michelon.
In lieu of cash, the company is paying this portion of management salaries in the form of restricted stock units. Amending its Director Compensation Policy to provide that its non-employee directors' annual retainers for the second, third and fourth fiscal quarters of 2020 will be paid in the form of restricted stock units instead of cash. "As the COVID-19 pandemic has unfolded, ENDRA has taken preemptive actions to align the company's cost structure with this environment, while also ensuring our ability to bring the TAEUS system to market in 2020," said Francois Michelon, CEO of ENDRA.
Newly Issued Patent Protects ENDRA's Innovative Design for its Fatty Liver Imaging Probe (FLIP) in China ANN ARBOR, MI / ACCESSWIRE / March 6, 2020 / ENDRA Life Sciences Inc. (''ENDRA'') (NASDAQ:NDRA), ...